Clinical characteristics, management and survival in young adults diagnosed with malignant melanoma: A population-based cohort study

Acta Oncologica

Volumn 53, Issue 5, 2014, Pages 688-696

  Plym, Anna ^a   Ullenhag, Gustav J ^b   Breivald, Mats ^c   Lambe, Mats ^a,d   Berglund, Anders ^b,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; MELANOMA; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEX DIFFERENCE; SWEDEN; YOUNG ADULT; EPIDEMIOLOGY; PATHOLOGY; REGISTER; AGED; CANCER DIAGNOSIS; CANCER STAGING; EXCISION; GROUPS BY AGE; SURVIVAL TIME;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HUMANS; MALE; MELANOMA; REGISTRIES; SWEDEN; YOUNG ADULT;

EID: 84921994897     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.854928     Document Type: Article

References (30)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010. [cited 2012 Nov 11]. Available from: http://globocan.iarc.fr
2. Cancerstatistik: The National Board of Health and Welfare (Socialstyrelsen). [cited 2013 May 29]. Available from: www. socialstyrelsen.se/statistik/statistikdatabas.
3. Engholm G, Ferlay J, Christensen N, Johannesen TB, Klint Å, K ø tlum J, et al. NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic countries, Version 5.2: Association of the Nordic Cancer Registries. Danish Cancer Society; 2012. [cited 2013 Jan 25]. Available from: http://www.ancr.nu.
4. Aben KK, van Gaal C, van Gils NA, van der Graaf WT, Zielhuis GA. Cancer in adolescents and young adults (15-29 years): A population-based study in the Netherlands 1989-2009. Acta Oncol 2012; 51: 922-33.
5. Purdue MP, Freeman LE, Anderson WF, Tucker MA. Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol 2008; 128: 2905-8.
6. Reed KB, Brewer JD, Lohse CM, Bringe KE, Pruitt CN, Gibson LE. Increasing incidence of melanoma among young adults: An epidemiological study in Olmsted County, Minnesota. Mayo Clin Proc 2012; 87: 328-34.
7. Bleyer A, Barr R. Cancer in young adults 20 to 39 years of age: Overview. Semin Oncol 2009; 36: 194-206.
8. Chagpar RB, Ross MI, Reintgen DS, Edwards MJ, Scoggins CR, Martin RC, et al. Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. J Surg Res 2007; 143: 164-8.
9. Weir HK, Marrett LD, Cokkinides V, Barnholtz-Sloan J, Patel P, Tai E, et al. Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol 2011; 65(5 Suppl 1): S38-49.
10. Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Moller T, et al. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Cancer 2004; 101: 2067-78.
11. Lasithiotakis KG, Leiter U, Gorkievicz R, Eigentler T, Breuninger H, Metzler G, et al. The incidence and mortality of cutaneous melanoma in Southern Germany: Trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer 2006; 107: 1331-9.
12. Tsai S, Balch C, Lange J. Epidemiology and treatment of melanoma in elderly patients. Nat Rev Clin Oncol 2010; 7: 148-52.
13. Regional rapport 1997-2008: Quality Register of Cutaneous Malignant Melanoma, Regional Cancer Centre in the Uppsala/Örebro region. [cited 2013 April 10]. Available from: http://www.cancercentrum.se/Global/RCCUppsalaOrebro/ Vårdprocesser/malignt-melanom/rapporter/reg-rapport- 2008.pdf.
14. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-48.
15. Nationellt v å rdprogram Malignt hudmelanom: The Swedish Melanoma Study Group; 2007. [cited 2013 Apr 10]. Available from: http://www.karolinska. se/upload/Onkologiskt %20centrum/NationellaVardprogram/Nat-vp-malignt- hudmelanom-2007.pdf.
16. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004; 23: 51-64.
17. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933-42.
18. Coelho SG, Hearing VJ. UVA tanning is involved in the increased incidence of skin cancers in fair-skinned young women. Pigment Cell Melanoma Res 2010; 23: 57-63.
19. Siskind V, Whiteman DC, Aitken JF, Martin NG, Green AC. An analysis of risk factors for cutaneous melanoma by anatomical site (Australia). Cancer Causes Control 2005; 16: 193-9.
20. Grange F, Vitry F, Granel-Brocard F, Lipsker D, Aubin F, Hedelin G, et al. Variations in management of stage I to stage III cutaneous melanoma: A population-based study of clinical practices in France. Arch Dermatol 2008; 144: 629-36.
21. Livingstone E, Windemuth-Kieselbach C, Eigentler TK, Rompel R, Trefzer U, Nashan D, et al. A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. Eur J Cancer 2011; 47: 1977-89.
22. Carpenter S, Pockaj B, Dueck A, Gray R, Kurtz D, Sekulic A, et al. Factors influencing time between biopsy and defini-tive surgery for malignant melanoma: Do they impact clinical outcome? Am J Surg 2008; 196: 834-42; discussion 42-3.
23. McKenna DB, Lee RJ, Prescott RJ, Doherty VR. The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival. Br J Dermatol 2002; 147: 48-54.
24. Kemeny MM, Busch E, Stewart AK, Menck HR. Superior survival of young women with malignant melanoma. Am J Surg 1998; 175: 437-44; discussion 44-5.
25. Lasithiotakis KG, Petrakis IE, Garbe C. Cutaneous melanoma in the elderly: Epidemiology, prognosis and treatment. Melanoma Res 2010; 20: 163-70.
26. Haniff J, de Vries E, Claassen AT, Looman CW, van Berlo C, Coebergh JW. Non-compliance with the re-excision guidelines for cutaneous melanoma in The Netherlands does not influence survival. Eur J Surg Oncol 2006; 32: 85-9.
27. Bilimoria KY, Balch CM, Wayne JD, Chang DC, Palis BE, Dy SM, et al. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States. J Clin Oncol 2009; 27: 1857-63.
28. Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: Relative survival vs cancer-specific survival. Int J Epidemiol 2010; 39: 598-610.
29. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: Concepts, methodologies, and guidelines. Annu Rev Public Health 1997; 18: 341-78.
30. MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009; 20(Suppl 6): vi1-7.